COST-EFFECTIVENESS OF DIMETHYL FUMARATE TREATMENT FOR RELAPSING REMITTING MULTIPLE SCLEROSIS FROM A DANISH PERSPECTIVE

被引：3
|
作者：
Olsen, J. [1 ]
Wiren, A. [2 ]
机构：
[1] HOLTE, Incent Aps, Copenhagen, Denmark
[2] Biogen Denmark AS, Copenhagen, Denmark
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2469
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND54
引用
收藏
页码：A758 / A758
页数：1
相关论文
共 50 条
  • [41] The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Kawalec, Pawel
    Mikrut, Alicja
    Wisniewska, Natalia
    Pilc, Andrzej
    CURRENT NEUROPHARMACOLOGY, 2014, 12 (03) : 256 - 268
  • [42] Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis
    Zhang, Xinke
    Hay, Joel W.
    Niu, Xiaoli
    CNS DRUGS, 2015, 29 (01) : 71 - 81
  • [43] Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis
    Xinke Zhang
    Joel W. Hay
    Xiaoli Niu
    CNS Drugs, 2015, 29 : 71 - 81
  • [44] COST-MINIMIZATION ANALYSIS OF TERIFLUNOMIDE AND DIMETHYL FUMARATE FOR TREATMENT OF RELAPSING-REMITTING FORMS OF MULTIPLE SCLEROSIS IN ITALY
    Stanisic, S.
    Bergamaschi, R.
    Berto, P.
    Di Procolo, P.
    Marocco, A.
    Morawski, J.
    VALUE IN HEALTH, 2018, 21 : S341 - S341
  • [45] Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study
    Kalincik, T.
    Spelman, T.
    Jokubaitis, V.
    Horakova, D.
    Havrdova, E.
    Izquierdo, G.
    Prat, A.
    Girard, M.
    Duquette, P.
    Lugaresi, A.
    Grammond, P.
    Alroughani, R.
    Lechner-Scott, J.
    Prevost, J.
    Terzi, M.
    Grand'Maison, F.
    Boz, C.
    Trojano, M.
    Van Wijmeersch, B.
    Pucci, E.
    Granella, F.
    Turkoglu, R.
    Sola, P.
    Ferraro, D.
    McCombe, P.
    Solaro, C.
    Van Pesch, V.
    Ozakbas, S.
    Slee, M.
    Spitaleri, D.
    Sanchez-Menoyo, J. L.
    Ampapa, R.
    Hodgkinson, S.
    Karabudak, R.
    Vucic, S.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 325 - 327
  • [46] Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis
    Luo, Hongxiu
    Bhatt, Harsh
    Mohamad, Shaza
    Uhrik, Eric
    Sen, Shuvendu
    Mathew, Teena
    Yousif, Abdalla
    JOURNAL OF NEUROLOGY, 2015, 262 (03) : 779 - 780
  • [47] Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
    Ozel, Osman
    Vaughn, Caila B.
    Eckert, Svetlana P.
    Jakimovski, Dejan
    Lizarraga, Alexis A.
    Weinstock-Guttman, Bianca
    PATIENT-RELATED OUTCOME MEASURES, 2019, 10 : 373 - 384
  • [48] Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis
    Hongxiu Luo
    Harsh Bhatt
    Shaza Mohamad
    Eric Uhrik
    Shuvendu Sen
    Teena Mathew
    Abdalla Yousif
    Journal of Neurology, 2015, 262 : 779 - 780
  • [49] COST-EFFECTIVENESS OF DACLIZUMAB VERSUS FINGOLIMOD IN THE TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN NORWAY
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Haines, P.
    Liu, Y.
    Bjornstad, B. M.
    Haukaas, F. S.
    VALUE IN HEALTH, 2016, 19 (07) : A433 - A433
  • [50] COST-EFFECTIVENESS ANALYSIS OF CLADRIBINE TABLETS FOR TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Dineva, T.
    Panayotov, P.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S206 - S206
12345